The effects of Ginkgo biloba leaf extract on metabolic disturbances associated to alloxan-induced diabetic rats.

Ginkgo biloba leaf extract (GBE) considered one of the most effective therapeutic herbs. We evaluated anti-diabetic activities of GBE in rats. Rats were fed highly-fat diet for two weeks and divided into three groups (n=8): Non-diabetic control group (CG), Diabetic group (DG), Diabetic+100mg/kg GBE group (D+GBE). On 14th day, the rats were kept in overnight-fasting and administered single intra-peritoneal injection of alloxan-monohydrate (120-130mg/Kg body weight (BW). BW and blood glucose were measured weekly up to 14th week. Fasting/basal blood samples were collected for the biochemical analyses. Liver, skeletal muscle and adipose tissue were also collected for mRNA gene expressions (GLUT4, IRS-1, IR, PEPCK, SREBP-1c, FAS, PPAR-α, PPAR-γ, TNF-α). Significant reduction in BW was found in D+GBE group at week 14. Glycemia became normalized as an effect of treatment. GBE significantly decreased serum glucose, urea and ALT concentrations. We observed significant higher catalase and lower malondialdehyde levels in D+GBE group. GBE significantly increased HDL-Cholesterol and reduced triglycerides and VLDL-Triglycerides levels. GBE showed up-regulation for hepatic IRS-1 and down-regulation for PEPCK, however, up-regulation for GLUT-4 and PPAR-α found in muscle. Treatment decreased TNF-α expression in liver and adipose tissue. GBE has anti-diabetic mediated by a modulating effect on involved key genes.

[1]  M. Unger.  Pharmacokinetic drug interactions involving Ginkgo biloba , 2013, Drug metabolism reviews.

[2]  L. Goya,et al.  Cocoa flavonoids improve insulin signalling and modulate glucose production via AKT and AMPK in HepG2 cells. , 2013, Molecular nutrition & food research.

[3]  Yunhui Li,et al.  Antihyperglycemic Effect of Ginkgo biloba Extract in Streptozotocin-Induced Diabetes in Rats , 2012, BioMed research international.

[4]  E. Maltaş,et al.  Evaluation of Phytochemicals and Antioxidant Activity of Ginkgo biloba from Turkey , 2012 .

[5]  K. Ahmed,et al.  The chemopreventive effect of Ginkgo biloba and Silybum marianum extracts on hepatocarcinogenesis in rats , 2011, Cancer Cell International.

[6]  Suin Cho,et al.  Effects of a multi-herbal extract on type 2 diabetes , 2011, Chinese medicine.

[7]  Ming-cheng Lin,et al.  Rutin inhibits oleic acid induced lipid accumulation via reducing lipogenesis and oxidative stress in hepatocarcinoma cells. , 2011, Journal of food science.

[8]  Li-Li Wu,et al.  Research progress on the mechanism of single-Chinese medicinal herbs in treating diabetes mellitus , 2011, Chinese Journal of Integrative Medicine.

[9]  J. Bland,et al.  Antidiabetic screening of commercial botanical products in 3T3-L1 adipocytes and db/db mice. , 2010, Journal of medicinal food.

[10]  B. Cha,et al.  Nobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob mice. , 2010, Biochemical pharmacology.

[11]  J. Moreno-Navarrete,et al.  Extracellular Fatty Acid Synthase: A Possible Surrogate Biomarker of Insulin Resistance , 2010, Diabetes.

[12]  M. Vinciguerra,et al.  Dietary Phytoestrogens Activate AMP-Activated Protein Kinase With Improvement in Lipid and Glucose Metabolism , 2008, Diabetes.

[13]  S. Nayak,et al.  Relationship between inflammatory markers, metabolic and anthropometric variables in the Caribbean type 2 diabetic patients with and without microvascular complications , 2006, Journal of Inflammation.

[14]  M. Javors,et al.  The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjects--a double blind placebo-controlled, crossover study. , 2006, Clinical nutrition.

[15]  N. Rao,et al.  Evaluation of Antidiabetic Activity of Ginkgo Biloba in Streptozotocin Induced Diabetic Rats , 2005 .

[16]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[17]  C. Nicol,et al.  Peroxisome proliferator‐activated receptor α is involved in the regulation of lipid metabolism by ginseng , 2003, British journal of pharmacology.

[18]  M. Krempf,et al.  The differential apoA-I enrichment of preβ1 and αHDL is detectable by gel filtration separation Published, JLR Papers in Press, September 1, 2002. DOI 10.1194/jlr.D200024-JLR200 , 2002, Journal of Lipid Research.

[19]  D. Granner,et al.  Epigallocatechin Gallate, a Constituent of Green Tea, Represses Hepatic Glucose Production* , 2002, The Journal of Biological Chemistry.

[20]  Joseph L Goldstein,et al.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.

[21]  G. Kudolo,et al.  The Effect of 3‐Month Ingestion of Ginkgo biloba Extract (EGb 761) on Pancreatic β‐Cell Function in Response to Glucose Loading in Individuals with Non‐Insulin‐Dependent Diabetes Mellitus , 2001, Journal of clinical pharmacology.

[22]  F. V. Defeudis,et al.  Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. , 2000, Current drug targets.

[23]  T. Forte,et al.  The role of apolipoprotein A‐l-containing lipoproteins in atherosclerosis , 1994, Current opinion in lipidology.

[24]  J. Baynes.  Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.

[25]  C. Bailey,et al.  Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice , 1990, Diabetologia.

[26]  J. Camps,et al.  Introduction: oxidation and inflammation, a molecular link between non-communicable diseases. , 2014, Advances in experimental medicine and biology.

[27]  Robby Kumar.  Correlation of Selenium and other antioxidants in diabetic patients with and without complications , 2012 .

[28]  S. Chung,et al.  Beneficial effects of IH-901 on glucose and lipid metabolisms via activating adenosine monophosphate-activated protein kinase and phosphatidylinositol-3 kinase pathways. , 2011, Metabolism: clinical and experimental.

[29]  Tao Qian,et al.  Ginkgo biloba extract enhances glucose tolerance in hyperinsulinism-induced hepatic cells , 2010, Journal of Natural Medicines.

[30]  O. Ebuehi,et al.  Oxidative stress in alloxan - induced diabetes in female and male rats. , 2009 .

[31]  M. Palacín,et al.  Mechanisms regulating GLUT4 glucose transporter expression and glucose transport in skeletal muscle. , 2005, Acta physiologica Scandinavica.

[32]  Yuan Luo,et al.  Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. , 2003, Journal of Alzheimer's disease : JAD.

[33]  S. Brichard,et al.  Treatment of streptozotocin-induced diabetic rats with vanadate and phlorizin prevents the over-expression of the liver insulin receptor gene. , 1999, European journal of endocrinology.